KLONOPIN RAPIDLY DISINTEGRATING
LOE ApproachingNDAORALTABLET, ORALLY DISINTEGRATING
Approved
Dec 1997
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 3d ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
KLONOPIN Rapidly Disintegrating is an orally disintegrating tablet formulation of clonazepam, a benzodiazepine small molecule approved in 1997. The drug is indicated for anxiety disorders and seizure management, working by enhancing GABA-mediated inhibition in the central nervous system. It is designed for patients requiring rapid onset or those with difficulty swallowing conventional tablets.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure (30/100), signaling smaller commercial teams and transition focus toward lifecycle management rather than growth.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on KLONOPIN Rapidly Disintegrating offers limited career growth in a LOE-approaching product with minimal linked job openings. Roles focus on defensive market management, payer negotiations, and maintaining existing market share rather than brand-building or launch activities.
Brand ManagerMarket Access Manager
Worked on KLONOPIN RAPIDLY DISINTEGRATING at Roche? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.